# Osteoporosis in Primary Hyperparathyroidism

> **NCT04085419** · PHASE4 · UNKNOWN · sponsor: **University Medical Centre Ljubljana** · enrollment: 40 (estimated)

## Conditions studied

- Primary Hyperparathyroidism
- Osteoporosis

## Interventions

- **DRUG:** Denosumab 60 MG/ML Prefilled Syringe [Prolia]
- **DRUG:** Zoledronic Acid

## Key facts

- **NCT ID:** NCT04085419
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-08
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04085419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04085419, "Osteoporosis in Primary Hyperparathyroidism". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04085419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*